E-LIB Suche - Ergebnisse für: Dewit, O

1

The potential of near infra-red interactance for predicting..:

Fuller, N J ; Dewit, O ; Wells, J C K
European Journal of Clinical Nutrition. 55 (2024) 11 - p. 967-972 , 2024

Link: https://doi.org/10.1038/..

2

DOP40 Corticosteroid discontinuation and clinical outcomes ..:

Dubinsky, M C ; D'Haens, G ; Dewit, O...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i104-i106 , 2023

Link: https://doi.org/10.1093/..

3

P521 Effectiveness of ustekinumab as therapy for chronic an..:

Outtier, A ; Louis, E ; Dewit, O...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i649-i650 , 2023

Link: https://doi.org/10.1093/..

4

P591 Negative impact of high body mass index on the efficac..:

Hamoir, F ; De Leuze, F ; Denis, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i719-i720 , 2023

Link: https://doi.org/10.1093/..

5

P472 Changes in colectomy for Ulcerative Colitis during the..:

Le Cosquer, G ; Capirchio, L ; Rivière, P...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i444-i444 , 2022

Link: https://doi.org/10.1093/..

6

P558 Should we introduce early a new biological agent in pa..:

Cottron, C ; Treton, X ; Altwegg, R...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i502-i503 , 2022

Link: https://doi.org/10.1093/..

7

How to Manage Inflammatory Bowel Disease Patients When They..:

Cottron, C ; Treton, X ; Altwegg, R...
Journal of Crohn's and Colitis. 16 (2022) 8 - p. 1202-1210 , 2022

Link: https://doi.org/10.1093/..

8

P496 Efficacy and safety of ustekinumab for chronic antibio..:

Outtier, A ; Louis, E ; Dewit, O...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i460-i461 , 2022

Link: https://doi.org/10.1093/..

9

OP28 A randomized placebo controlled clinical trial with 5-..:

Truyens, M ; Lobaton, T ; Peeters, A...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i029-i032 , 2022

Link: https://doi.org/10.1093/..

10

OP27 Long-term safety and efficacy of risankizumab treatmen..:

Ferrante, M ; Feagan, B G ; Panés, J...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S024-S025 , 2020

Link: https://doi.org/10.1093/..

11

P422 Tofacitinib induces clinical and endoscopic remission ..:

Cremer, A ; Lobaton, T ; Vieujan, S...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S384-S386 , 2020

Link: https://doi.org/10.1093/..

12

P694 Genetic predisposition and thiopurine-induced pancreat..:

Burnet, G ; de Suray, N ; De Vroey, B...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S467-S467 , 2019

Link: https://doi.org/10.1093/..

13

P723 Effectiveness and persistence of vedolizumab in patien..:

Reenaers, C ; Cremer, A ; Dewit, O...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S476-S477 , 2018

Link: https://doi.org/10.1093/..

14

DOP011 Risk of opportunistic infection in healthcare person..:

Gagniere, C. ; Bourrier, A. ; Seksik, P....
Journal of Crohn's and Colitis. 11 (2017) suppl_1 - p. S31-S32 , 2017

Link: https://doi.org/10.1093/..

15

P732 Clinical characteristics of inflammatory bowel disease..:

de Ville de Goyet, L. ; Moreels, T. ; Denis, M.A....
Journal of Crohn's and Colitis. 11 (2017) suppl_1 - p. S455-S455 , 2017

Link: https://doi.org/10.1093/..